Publication | Open Access
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
86
Citations
52
References
2023
Year
These studies identify and characterize a new type of human acute myeloid LSC that is responsible for monocytic disease progression in patients with AML treated with venetoclax-based regimens. Our studies describe the phenotype, molecular properties, and drug sensitivities of this unique LSC subclass. This article is featured in Selected Articles from This Issue, p. 1949.
| Year | Citations | |
|---|---|---|
2012 | 53.2K | |
2021 | 14.9K | |
2018 | 8.6K | |
1997 | 6.9K | |
1976 | 5.6K | |
2019 | 4.7K | |
2019 | 4.2K | |
2006 | 1.5K | |
2011 | 1K | |
2004 | 969 |
Page 1
Page 1